Literature DB >> 10859498

Prevalence of Alzheimer's disease and other dementing disorders in an urban community of Beijing, China.

W Wang1, S Wu, X Cheng, H Dai, K Ross, X Du, W Yin.   

Abstract

A door-to-door two-phase study was used to investigate the prevalence of senile dementia in an urban community of Beijing. In the study population, 5,003 individuals aged 60 years and older (>/=65 years, n = 3,728) were screened at home with the Chinese version of the MMSE. Persons who screened positive for dementia, using different cutoff scores based on degree of literacy, were further evaluated using the criteria of DSM-III-R and ICD-10. Among subjects who screened positive in phase I, 134 were diagnosed as having dementia in phase II. The prevalence ratios of dementia were 2.68% in the population aged 60 years and older, and 3.49% in the population aged 65 years and older. The prevalence rates among those aged 65 years and older were 1.85% for Alzheimer's disease, 1.37% for vascular dementia and 0.27% for other dementia (including mixed dementia). The prevalence of all dementia and AD increased steeply with advancing age and was consistently higher in women, but it was not obviously higher for VaD in women. Alzheimer's disease was the commonest type of dementia. Our prevalence figures for dementia and AD are similar to those previously reported for China. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2000        PMID: 10859498     DOI: 10.1159/000026255

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  9 in total

1.  Seizures in setting of dementia.

Authors:  Kartik Sivaraaman; Vimala S Vajjala
Journal:  Curr Treat Options Neurol       Date:  2015-04       Impact factor: 3.598

2.  Recurrent seizures in patients with dementia: frequency, seizure types, and treatment outcome.

Authors:  Satish C Rao; Gerald Dove; Gregory D Cascino; Ronald C Petersen
Journal:  Epilepsy Behav       Date:  2008-10-08       Impact factor: 2.937

Review 3.  Dementia studies in Chinese populations.

Authors:  Jin-Jing Pei; Maria Stella T Giron; Jianping Jia; Hui-Xin Wang
Journal:  Neurosci Bull       Date:  2014-03-14       Impact factor: 5.203

4.  Utility of AD8 for cognitive impairment in a Chinese physical examination population: a preliminary study.

Authors:  Yue Xie; Ya Gao; Jianjun Jia; Xiaohong Wang; Zhenfu Wang; Hengge Xie
Journal:  ScientificWorldJournal       Date:  2014-11-10

5.  Prevalence of Alzheimer's dementia and its risk factors in community-dwelling elderly koreans.

Authors:  Seok-Ju Choi; Sung-Soo Jung; Young-Sun You; Bae-Seob Shin; Ji-Eun Kim; Sung-Wook Yoon; Dong-Wook Jeon; Jun-Hyung Baek; Sung-Woo Park; Jung-Goo Lee; Young-Hoon Kim
Journal:  Psychiatry Investig       Date:  2008-06-30       Impact factor: 2.505

Review 6.  Prevalence studies of dementia in mainland china, Hong Kong and taiwan: a systematic review and meta-analysis.

Authors:  Yu-Tzu Wu; Hsin-Yi Lee; Samuel Norton; Chuanfeng Chen; Hongxia Chen; Chenglin He; Jane Fleming; Fiona E Matthews; Carol Brayne
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

7.  Apolipoprotein E4 causes age- and sex-dependent impairments of hilar GABAergic interneurons and learning and memory deficits in mice.

Authors:  Laura Leung; Yaisa Andrews-Zwilling; Seo Yeon Yoon; Sachi Jain; Karen Ring; Jessica Dai; Max Mu Wang; Leslie Tong; David Walker; Yadong Huang
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

8.  Prevalence of dementia and Alzheimer's disease in elders of nursing homes and a senior center of Durango City, Mexico.

Authors:  Cosme Alvarado-Esquivel; Ana Berthina Hernández-Alvarado; Rosa Oralia Tapia-Rodríguez; Angel Guerrero-Iturbe; Karina Rodríguez-Corral; Sergio Estrada Martínez
Journal:  BMC Psychiatry       Date:  2004-02-18       Impact factor: 3.630

Review 9.  Global epidemiology of dementia: Alzheimer's and vascular types.

Authors:  Liara Rizzi; Idiane Rosset; Matheus Roriz-Cruz
Journal:  Biomed Res Int       Date:  2014-06-25       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.